These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 12647312

  • 1. Selection criteria for drug-like compounds.
    Muegge I.
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [Abstract] [Full Text] [Related]

  • 2. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
    Dobson PD, Patel Y, Kell DB.
    Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901
    [Abstract] [Full Text] [Related]

  • 3. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR.
    Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
    [Abstract] [Full Text] [Related]

  • 4. The devil is still in the details--driving early drug discovery forward with biophysical experimental methods.
    Lundqvist T.
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):513-9. PubMed ID: 16022188
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T, Krovat EM.
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY, Itai A.
    J Med Chem; 2004 Sep 23; 47(20):4818-28. PubMed ID: 15369385
    [Abstract] [Full Text] [Related]

  • 10. Pursuing the leadlikeness concept in pharmaceutical research.
    Hann MM, Oprea TI.
    Curr Opin Chem Biol; 2004 Jun 23; 8(3):255-63. PubMed ID: 15183323
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Streamlining lead discovery by aligning in silico and high-throughput screening.
    Davies JW, Glick M, Jenkins JL.
    Curr Opin Chem Biol; 2006 Aug 23; 10(4):343-51. PubMed ID: 16822701
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chemical complementation: a definitive phenotypic strategy for identifying small molecule inhibitors of elusive cellular targets.
    Vogt A, Lazo JS.
    Pharmacol Ther; 2005 Aug 23; 107(2):212-21. PubMed ID: 15925410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.